Metabolic risk profiles in diabetes stratified according to age at onset, islet autoimmunity and fasting C-peptide

Our results demonstrate that fasting C-peptide and GADab status, but not age at onset, define groups of patients with diabetes with clinically relevant differences in glycaemic control and cardiometabolic risk.